January 30, 2019
Belimumab in Remission of VASculitis
Read More
January 30, 2019
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Read More
January 30, 2019
TroVax Renal Immunotherapy Survival Trial
Read More
January 30, 2019
TroVax Renal Immunotherapy Survival Trial
Read More
January 30, 2019
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection
Read More
January 30, 2019
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection
Read More
January 30, 2019
Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Read More
January 30, 2019
Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)
Read More
January 30, 2019
Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy
Read More
January 30, 2019
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
Read More
January 30, 2019
A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Read More
Load More
X